Investor Farallon Capital Partners, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Farallon Capital Partners, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-09-08 13G CRNX / Crinetics Pharmaceuticals, Inc. 5,625,098
2025-08-15 13G ASMB / Assembly Biosciences, Inc. 1,140,510
2025-08-13 13G/A TNGX / Tango Therapeutics, Inc. 7,182,000 9,157,000
2025-08-13 13G/A BBNX / Beta Bionics, Inc. 4,203,920
2025-08-12 13G/A NYT / The New York Times Company 9,011,576 5,609,546
2025-08-12 13G/A ARMK / Aramark 16,241,996 12,899,701
2025-07-11 13G LQDA / Liquidia Corporation 6,832,472
2025-06-20 13G MEHCQ / Chrome Holding Co. 1,270,908
2025-06-13 13G TNGX / Tango Therapeutics, Inc. 7,182,000
2025-05-20 13D/A EXEL / Exelixis, Inc. 23,439,500 18,635,500
2025-05-15 13G/A RVMD / Revolution Medicines, Inc. 6,750,204 13,262,045
2025-05-15 13G/A RVMD / Revolution Medicines, Inc. 6,750,204 11,331,045
2025-05-15 13G RVMD / Revolution Medicines, Inc. 6,750,204 8,376,225
2025-05-13 13G/A BEAM / Beam Therapeutics Inc. 8,239,123 9,972,980
2025-05-08 13G/A ISR / Perspective Therapeutics Inc 5,316,227 6,023,227
2025-05-07 13G/A ARMK / Aramark 13,638,340 16,241,996
2025-05-07 13G/A ELEV / Elevation Oncology, Inc. 3,527,482 0
2025-03-05 13D/A EXEL / Exelixis, Inc. 26,769,500 23,439,500
2025-02-18 13G ARMK / Aramark 11,636,937 13,638,340
2025-02-18 13G NYT / The New York Times Company 9,011,576
2025-02-11 13G/A SVRA / Savara Inc. 17,762,533 18,288,986
2025-02-11 13G/A ENTA / Enanta Pharmaceuticals, Inc. 2,025,000 2,108,262
2025-02-10 13G/A ANNA / AleAnna, Inc. 1,068,400
2025-02-10 13G/A 3,793,497 221,027
2025-02-10 13G/A PTGX / Protagonist Therapeutics, Inc. 5,765,109 5,956,488
2025-02-05 13G/A BEAM / Beam Therapeutics Inc. 8,208,123 8,239,123
2025-02-05 13G/A NYT / The New York Times Company 9,476,791 7,376,113
2025-02-05 13G/A ELEV / Elevation Oncology, Inc. 3,527,482 3,527,482
2025-02-05 13G/A ISR / Perspective Therapeutics Inc 5,064,227 5,316,227
2025-02-04 13G/A AGIO / Agios Pharmaceuticals, Inc. 5,660,866 5,674,466
2024-11-14 13G ISR / Perspective Therapeutics Inc 5,064,227
2024-11-08 13G/A LBPH / Longboard Pharmaceuticals, Inc. 2,205,990 3,456,063
2024-11-08 13G/A ARMK / Aramark 16,899,254 11,636,937
2024-11-08 13G/A AGIO / Agios Pharmaceuticals, Inc. 4,167,602 5,660,866
2024-11-08 13G/A ELEV / Elevation Oncology, Inc. 3,100,000 3,527,482
2024-11-07 13G/A BEAM / Beam Therapeutics Inc. 4,105,753 8,208,123
2024-11-06 13G/A SVRA / Savara Inc. 14,326,911 17,762,533
2024-11-06 13G/A IVCP / Swiftmerge Acquisition Corp. 525,000 471,366
2024-10-16 13D SQSP / Squarespace, Inc. 5,600,000
2024-05-17 13G NSTGQ / NS Wind Down Co., Inc. 4,391,941
2024-05-08 13D/A EXEL / Exelixis, Inc. 25,860,000 26,769,500
2024-02-14 13G/A FBRX / Forte Biosciences, Inc. 3,787,636 3,793,497
2024-02-12 13G/A RVMD / Revolution Medicines, Inc. 6,762,480 6,750,204
2024-02-12 13G/A BEAM / Beam Therapeutics Inc. 4,113,469 4,105,753
2024-02-08 13G/A AGIO / Agios Pharmaceuticals, Inc. 3,961,602 4,167,602
2024-02-06 13G/A ARMK / Aramark 15,381,069 16,899,254
2024-02-05 13D/A CZOOF / Cazoo Group Ltd 714,240
2024-02-05 13G/A IVCP / Swiftmerge Acquisition Corp. 2,205,000 525,000
2024-02-02 13G/A PTGX / Protagonist Therapeutics, Inc. 5,055,102 5,765,109
2024-02-01 13G/A SVRA / Savara Inc. 11,532,622 14,326,911
2024-01-30 13G/A BACA / Berenson Acquisition Corp. I 2,662,500 413,113
2024-01-30 13G/A LBPH / Longboard Pharmaceuticals, Inc. 1,417,917 2,205,990
2024-01-26 13G/A ENTA / Enanta Pharmaceuticals, Inc. 1,550,000 2,025,000
2024-01-25 13G/A FRXB / Forest Road Acquisition Corp II - Class A 400,000 0
2024-01-24 13G/A AVRO / AVROBIO, Inc. 3,116,000 0
2024-01-22 13G ELEV / Elevation Oncology, Inc. 3,100,000
2024-01-19 13G/A KYG2770Y1281 / DISRUPTIVE ACQUISITION COR A DISRUPTIVE ACQ CL A CW26 0
2024-01-18 13G/A ARYD / ARYA Sciences Acquisition Corp IV 800,000 200,000
2024-01-02 13G NYT / The New York Times Company 9,476,791
2023-12-08 13D/A CZOOF / Cazoo Group Ltd 714,240
2023-11-09 13G AGIO / Agios Pharmaceuticals, Inc. 3,961,602
2023-11-09 13G RVMD / Revolution Medicines, Inc. 6,762,480
2023-11-07 13D/A CZOO / Cazoo Group Ltd 1,000,000 1,000,000
2023-10-16 13G ARMK / Aramark 10,828,884 15,381,069
2023-09-22 13D/A CZOO / Cazoo Group Ltd 1,000,000 1,000,000
2023-09-22 13G BEAM / Beam Therapeutics Inc. 3,399,921 4,113,469
2023-08-11 13D KDNY / Chinook Therapeutics Inc 7,110,000
2023-08-10 13G FBRX / Forte Biosciences, Inc. 3,787,636
2023-06-16 13D/A CZOO / Cazoo Group Ltd 1,000,000 1,000,000
2023-06-02 13D/A EXEL / Exelixis, Inc. 23,466,000 25,860,000
2023-05-16 13D/A CZOO / Cazoo Group Ltd 1,000,000 1,000,000
2023-04-27 13D/A CZOO / Cazoo Group Ltd 1,000,000 1,000,000
2023-04-07 13D/A EXEL / Exelixis, Inc. 23,466,000 23,466,000
2023-04-06 13G FRXB / Forest Road Acquisition Corp II - Class A 400,000
2023-03-27 13D/A EXEL / Exelixis, Inc. 23,466,000 23,466,000
2023-03-24 13D CZOO / Cazoo Group Ltd 1,000,000
2023-03-20 13D EXEL / Exelixis, Inc. 23,466,000
2023-02-17 13G AVRO / AVROBIO, Inc. 3,116,000
2023-02-14 13G/A BEAM / Beam Therapeutics Inc. 3,551,771 3,399,921
2023-02-09 13G/A IVCP / Swiftmerge Acquisition Corp. 2,205,000
2023-02-09 13G/A 822821104 / Shelter Acquisition Corp. I 0
2023-02-09 13G/A PTGX / Protagonist Therapeutics, Inc. 5,055,102
2023-02-07 13G/A BTTX / Better Therapeutics, Inc. 1,350,000 813,556
2023-02-07 13G/A AMRSQ / Amyris, Inc. 1,000,000
2023-02-07 13G/A CLVT / Clarivate Plc 35,325,900 15,177,433
2023-02-06 13G/A SEPA / SEP Acquisition Corp. 0
2023-02-06 13G/A ENTA / Enanta Pharmaceuticals, Inc. 1,550,000
2023-02-03 13G/A SVRA / Savara Inc. 11,532,622
2023-02-03 13G/A ARMK / Aramark 16,311,384 10,828,884
2023-02-03 13G/A LBPH / Longboard Pharmaceuticals, Inc. 1,417,917
2023-02-01 13G/A US08954L1109 / Big Sky Growth Partners, Inc. 0
2023-02-01 13G/A GBIO / Generation Bio Co. 1,249,382
2023-02-01 13G/A IMGO / Imago BioSciences Inc 2,671,313 0
2023-01-31 13G/A DISA / Disruptive Acquisition Corporation I 1,400,000
2023-01-31 13G/A BACA / Berenson Acquisition Corp. I 2,662,500
2023-01-31 13G/A ARYD / ARYA Sciences Acquisition Corp IV 800,000 800,000
2022-10-07 13D CHNG / Change Healthcare Inc 18,076,272
2022-09-07 13G CLVT / Clarivate Plc 35,325,900 35,325,900
2022-07-14 13G BEAM / Beam Therapeutics Inc. 3,551,771
2021-11-09 13G SEDA.U / SDCL EDGE Acquisition Corporat Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant 1,732,500
2021-11-08 13G / Mountain Crest Acquisition Corp. II 1,350,000
2021-10-12 13G US56608A2042 / Marblegate Acquisition Corp. 2,970,000
2021-10-08 13G BACA.U / Berenson Acquisition Corp. I U Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant 2,475,000
2021-10-01 13G KYG478741054 / INFLECTION POINT ACQUISITION SPECIAL PURPOSE ACQUISITION COMPANIES 1,900,000
2021-08-17 13G ARMK / Aramark 16,311,384
2021-08-06 13G US5893812017 / MERCURY ECOMMERCE ACQUISITIO SPECIAL PURPOSE ACQUISITION COMPANIES 1,732,500
2021-08-03 13G CRBU / Caribou Biosciences, Inc. 3,356,969
2021-07-27 13G IMGO / Imago BioSciences Inc 2,671,313
2021-07-07 13G SHQA / Shelter Acquisition Corp I - Class A 1,650,000
2021-05-10 13G ARYD / ARYA Sciences Acquisition Corp IV 800,000 800,000
2021-05-10 13G DISAU / Disruptive Acquisition Corp I - Units (1 Ord Share Class A & 1/3 War) 1,400,000 1,400,000
2021-05-10 13G 24279D204 / Decarbonization Plus Acquisition Corp III 2,000,000
2021-05-10 13G BSKYU / Big Sky Growth Partners Inc - Units (1 Ord Share Class A & 1/4 War) 1,550,000 1,550,000
2021-05-10 13G DISAU / Disruptive Acquisition Corp I - Units (1 Ord Share Class A & 1/3 War) 1,400,000 1,400,000
2021-05-10 13G US08954L2016 / Big Sky Growth Partners, Inc. 1,550,000 1,550,000
2021-05-10 13G ARYD / ARYA Sciences Acquisition Corp IV 800,000 800,000
2021-05-10 13G 24279D204 / Decarbonization Plus Acquisition Corp III 2,000,000
2021-04-30 13G / Khosla Ventures Acquisition Co. II Class A 2,250,000